Menu Close

Artikel-artikel mengenai Dopamine

Menampilkan 21 - 38 dari 38 artikel

Naloxone is often used to revive people overdosing from opioids. REUTERS/Brian Snyder

Why genetics makes some people more vulnerable to opioid addiction – and protects others

Scientists are just starting to understand how your parents' genes and experiences might shape your own susceptibility to dangerous drugs. Could that help to stop addictions before they start?
As North America’s opioid crisis worsens, schools across Canada are purchasing naloxone anti-overdose kits. Research suggests that risks of opioid addiction could also be addressed through attention to children’s nutrition. (Shutterstock)

Sugar in the diet may increase risks of opioid addiction

High fructose corn syrup in food and drinks has long been linked to rising rates of child and teen obesity. New evidence suggests it increases the risks of opioid addiction and overdose too.
Volunteering boosts your health. Dragon Images/Shutterstock.com

Why doing good can do you good

Scientists have found that there are many physical and mental benefits to volunteering.
Food can prompt behaviours and brain responses similar to those seen in more traditional forms of addiction. Justin McGregor/Shutterstock

Explainer: can you be addicted to food?

Are you a "carb craver" or "chocaholic"? We often use language associated with addiction to describe our relationships with food. But is it really possible to be addicted to certain types of food?
Video games have some clever ways of motivating players, and these methods can be used to get kids interested in learning. From www.shutterstock.com

Here’s the drug that every school should legalise

There may be a chemical secret to getting kids interested in learning – and it's one that's created and produced by our own bodies rather than in a lab.
Excess dopamine activity is not the only neurological change seen in patients with schizophrenia. Image from shutterstock.com

Why we shouldn’t ditch the quest for new schizophrenia drugs

The landscape of pharmaceutical development for mental disorders has changed over recent years, with pharma companies abandoning traditional neuroscience drug discovery programs and turning instead to…

Kontributor teratas

Lebih banyak